Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 1,840 |
|
|||||
| News | - | ||||||
| Day High | 1.50 | Low High |
|||||
| Day Low | 1.485 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| OKYO Pharma Ltd | OKYO | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 1.50 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.50 | 1.485 | 1.50 | 1.50 | 1.50 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 53 | 1,840 | US$ 1.49 | US$ 2,749 | - | 0.9201 - 3.25 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:45:38 | 4 | US$ 1.50 | USD |
OKYO Pharma Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 38.28M | 25.52M | - | 0 | -3.98M | -0.16 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
OKYO Pharma News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical OKYO Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.38 | 1.57 | 1.38 | 1.43 | 16,441 | 0.12 | 8.70% |
| 1 Month | 1.51 | 1.57 | 1.30 | 1.41 | 24,842 | -0.01 | -0.66% |
| 3 Months | 1.27 | 1.90 | 1.27 | 1.62 | 179,824 | 0.23 | 18.11% |
| 6 Months | 1.62 | 2.12 | 1.19 | 1.66 | 109,987 | -0.12 | -7.41% |
| 1 Year | 1.26 | 3.25 | 0.9201 | 2.07 | 165,122 | 0.24 | 19.05% |
| 3 Years | 4.50 | 7.00 | 0.9201 | 2.52 | 182,917 | -3.00 | -66.67% |
| 5 Years | 4.50 | 7.00 | 0.9201 | 2.52 | 182,917 | -3.00 | -66.67% |
OKYO Pharma Description
| OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions on various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain. |
